We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.5B
AUM Growth
+$2.63B
Cap. Flow
-$358M
Cap. Flow %
-1.01%
Top 10 Hldgs %
19.61%
Holding
1,339
New
136
Increased
426
Reduced
527
Closed
93

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$78.4M
2
STLA icon
Stellantis
STLA
+$64.2M
3
AAPL icon
Apple
AAPL
+$56.5M
4
CINF icon
Cincinnati Financial
CINF
+$36.6M
5
MA icon
Mastercard
MA
+$33.9M

Top Sells

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$121M
2
EPAM icon
EPAM Systems
EPAM
+$65.3M
3
NVDA icon
NVIDIA
NVDA
+$47.2M
4
VLO icon
Valero Energy
VLO
+$46.8M
5
AMAT icon
Applied Materials
AMAT
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 30.03%
2 Healthcare 16.84%
3 Consumer Discretionary 12.32%
4 Financials 10.53%
5 Industrials 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMP icon
801
Standard Motor Products
SMP
$902M
$2.69M 0.01%
62,100
+44,000
+243% +$1.97M
CRTO icon
802
Criteo S.A. Ordinary Shares
CRTO
$1.14B
$2.69M 0.01%
59,400
-90,000
-60% -$3.47M
ACM icon
803
Aecom
ACM
$9.46B
$2.67M 0.01%
42,200
CC icon
804
Chemours
CC
$2.48B
$2.66M 0.01%
76,500
-40,700
-35% -$1.35M
STZ icon
805
Constellation Brands
STZ
$22.5B
$2.65M 0.01%
11,332
-36
-0.3% -$8.45K
SFM icon
806
Sprouts Farmers Market
SFM
$7.44B
$2.65M 0.01%
106,600
-12,100
-10% -$323K
FLS icon
807
Flowserve
FLS
$8.94B
$2.65M 0.01%
65,600
MOG.A icon
808
Moog Inc Class A
MOG.A
$12.4B
$2.64M 0.01%
31,400
-17,100
-35% -$1.48M
ACHL
809
DELISTED
Achilles Therapeutics
ACHL
$2.63M 0.01%
+269,135
New +$3.65M
APLS
810
DELISTED
Apellis Pharmaceuticals
APLS
$2.61M 0.01%
41,321
-3,140
-7% -$162K
SBNY
811
DELISTED
Signature Bank
SBNY
$2.6M 0.01%
+10,600
New +$2.57M
LPLA icon
812
LPL Financial
LPLA
$27B
$2.56M 0.01%
19,000
-117,800
-86% -$17.1M
PNFP icon
813
Pinnacle Financial Partners Inc
PNFP
$15.8B
$2.56M 0.01%
29,000
-30,500
-51% -$2.73M
KGC icon
814
Kinross Gold
KGC
$27.7B
$2.56M 0.01%
402,600
-481,300
-54% -$3.57M
FBIN icon
815
Fortune Brands Innovations
FBIN
$5.86B
$2.56M 0.01%
30,007
+20,087
+202% +$1.76M
UNIT
816
Uniti Group
UNIT
$2.52B
$2.54M 0.01%
+239,800
New +$2.6M
ROL icon
817
Rollins
ROL
$18.6B
$2.52M 0.01%
73,638
ECOM
818
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$2.51M 0.01%
102,400
-23,700
-19% -$570K
VALE icon
819
Vale
VALE
$62.3B
$2.49M 0.01%
109,228
+379
+0.3% +$7.92K
STN icon
820
Stantec
STN
$8.17B
$2.48M 0.01%
55,700
+5,300
+11% +$239K
SNV
821
DELISTED
Synovus
SNV
$2.48M 0.01%
+56,600
New +$2.66M
STEM icon
822
Stem
STEM
$44.3M
$2.47M 0.01%
3,430
-246
-7% -$134K
RSG icon
823
Republic Services
RSG
$67.4B
$2.46M 0.01%
22,359
+1,426
+7% +$153K
LVTX
824
DELISTED
LAVA Therapeutics
LVTX
$2.4M 0.01%
220,663
+300
+0.1% +$3.72K
SPLK
825
DELISTED
Splunk Inc
SPLK
$2.36M 0.01%
16,328
-7,108
-30% -$905K

Similar funds

Axa's Q2 2021 Portfolio in Review

As of Q2 2021, Axa held 1,339 positions worth $35.5B, up 8% from $32.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa's Q2 2021 filing shows 136 new, 426 increased, 527 reduced and 93 closed positions. Its largest new stake was Sprinklr: 1,100,000 shares worth $22.6M. The largest sale was Proofpoint, Inc., an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2021 buy was Sprinklr: 1,100,000 shares worth $22.6M.
  • Axa added most to Berkshire Hathaway Class B in Q2 2021, an estimated $78.4M increase.
  • Axa's biggest Q2 2021 reduction was Proofpoint, Inc., cutting an estimated $121M.
  • Axa fully exited Arthur J. Gallagher & Co in Q2 2021, selling an estimated $33.5M.
  • Axa's ten largest holdings make up 20% of its $35.5B portfolio in Q2 2021.
  • Axa opened 136 new positions and closed 93 in Q2 2021.
  • Axa's portfolio value rose 8% quarter-over-quarter to $35.5B.

Based on Axa's 13F filing for Q2 2021, filed 13 Aug 2021.